Dr. Kurian participated in an interview with NPR recently and discussed genetic risk for cancer and under testing.

Dr Kurian discussed her recent work highlighting under testing in an NPR article.

Dr. Allison Kurian’s and Dr. Steven Katz’s recent paper published on June 5th, 2023 and featured in JAMA, describes the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019.

Her research has been featured in Stanford Medicine and USA Today.

Dr. Allison Kurian’s publication on recent chemotherapy trends featured in New York Times’ article about reducing use of chemotherapy for cancer treatment.

Genetic testing is vital for women with breast and ovarian cancers in order to determine the best treatment for each woman. Dr. Allison Kurian’s recent paper published on February 9th, 2021 is featured by Stanford Medicine’s Scope Blog to discuss the importance of genetic testing in greater detail.

Additional coverage of this paper can be found at: The ASCO Post | OncLive | MedScape

Dr. Chris Friese receives a $2 million grant from the National Cancer Institute to help University of Michigan Rogel Cancer Center researchers prepare the next generation of scientists focused on cancer care delivery.

A recent paper by Dr. Allison Kurian published in JAMA is highlighted by Michigan’s Rogel Cancer Center.